Accelerate Diagnostics (AXDX) reported Q3 EPS of ($0.18), $0.02 better than the analyst estimate of ($0.20). Revenue for the quarter came in at $2.96 million versus the consensus estimate of $3.75 million.
Accelerate Diagnostics (AXDX) reported Q3 EPS of ($0.18), $0.02 better than the analyst estimate of ($0.20). Revenue for the quarter came in at $2.96 million versus the consensus estimate of $3.75 million.